Nicole Goodwin Email & Phone Number
@gsk.com
LinkedIn matched
Who is Nicole Goodwin? Overview
A concise factual answer block for searchers comparing this professional profile.
Nicole Goodwin is listed as Director, Discovery Chemistry at Merck, based in Greater Philadelphia, United States, United States. AeroLeads shows a work email signal at gsk.com and a matched LinkedIn profile for Nicole Goodwin.
Nicole Goodwin previously worked as Director, Medicinal Chemistry, Modality Platform Technologies at Gsk and External Engagement and Recruitment Lead at Gsk. Nicole Goodwin holds Ph.D., Organic Chemistry from Caltech.
Email format at Merck
This section adds company-level context without repeating Nicole Goodwin's masked contact details.
AeroLeads found 2 current-domain work email signals for Nicole Goodwin. Compare company email patterns before reaching out.
About Nicole Goodwin
Highly motivated and enthusiastic matrix team leader with excellent interpersonal and influencing skills Management of high performing, highly collaborative international cross-functional scientific teams and/or direct reporting lines Demonstrated delivery of complex platform strategies and builds, enabling portfolio progression and evolution of ways of working in medicinal chemistry Passionate about scientific and personal development of others An inventor of sotagliflozin, a dual SGLT1/2 inhibitor marketed as Zynquista™ (type 1 diabetes) and Inpefa™ (heart failure)
Listed skills include Medicinal Chemistry, Organic Chemistry, Organic Synthesis, Drug Discovery, and 3 others.
Nicole Goodwin's current company
Company context helps verify the profile and gives searchers a useful next step.
Nicole Goodwin work experience
A career timeline built from the work history available for this profile.
Director, Medicinal Chemistry, Modality Platform Technologies
CurrentFocusing on non-traditional small molecules, including but not limited to oligonucleotides, degraders, and ADCs
External Engagement And Recruitment Lead
CurrentUS Medicinal Chemistry Recruitment Lead (2020-2022) and sponsor (2023-present)Advisory Board Member, Founding Industrial Member: University of Wisconsin-Madison, SynCat Center (2021 - present)Departmental responsibility of external engagement activities, including internships, social media, internal seminars, external academic collaborations
Director, Discovery High Throughput And Medicinal Chemistry
Leadership of US High Throughput Chemistry group in GSK Medicinal Chemistry, focusing on driving culture change of how medicinal chemists implement high throughput and automation tools for efficiency in DMTA cycles.
Vice Chair
CurrentIndustrial Vice Chair (2024), Executive Committee member, Chair of Long Range Planning Committee (2024)
Co-Chair, Princeton Acs Fall Organic Symposium
Senior Research Scientist (Medicinal Chemistry)
Chemistry project leader for LX2761, a locally-acting SGLT1 inhibitor for the treatment of diabetes, where responsibilities and achievements included: - Led the team from discovery to pre-clinical nomination in 14 months - Supervision of a team of up to four medicinal chemists - Interacted with biology colleagues and management to maintain a forward.
Research Scientist Ii (Medicinal Chemistry)
Chemistry project leader for an LX7101 (LIM Kinase 2 inhibitor, phase 1 for glaucoma) back-up program, where responsibilities and achievements included (in addition to above): - Supervision of a team of up to six medicinal chemists - Examined literature, HTS data, and an x-ray structure to develop three distinct chemotypes that all achieved in vivo.
Research Scientist I (Medicinal Chemistry)
Lead optimization and process discovery chemistry of LX4211, FDA- and EMA-approved SGLT1/2 inhibitor for the treatment of heart failure and type 1 diabetes, respectively. - Helped identify a new synthetic strategy to allow for large-scale preparation of LX4211 - Developed a robust oxidation procedure that was used in the process chemistry synthesis of.
Graduate Student, Macmillan Group
Total syntheses of (–)-Spiculisporic acid and (+)-5-epi-Spiculisporic acid - Developed the first asymmetric organocatalytic Mukaiyama-Michael addition of siloxyfurans into α,β-unsaturated aldehydes - Discovered a remarkable reversal of diastereoselectivity with electron-poor siloxyfuransInvestigated the total synthesis of Cylindrocyclophane F - Developed a.
Nicole Goodwin education
Ph.D., Organic Chemistry
H.B.S., Chemistry
Bachelor Of Science - Bs, Chemistry
Frequently asked questions about Nicole Goodwin
Quick answers generated from the profile data available on this page.
What company does Nicole Goodwin work for?
Nicole Goodwin works for Merck.
What is Nicole Goodwin's role at Merck?
Nicole Goodwin is listed as Director, Discovery Chemistry at Merck.
What is Nicole Goodwin's email address?
AeroLeads has found 2 work email signals at @gsk.com for Nicole Goodwin at Merck.
Where is Nicole Goodwin based?
Nicole Goodwin is based in Greater Philadelphia, United States, United States while working with Merck.
What companies has Nicole Goodwin worked for?
Nicole Goodwin has worked for Merck, Gsk, Acs Division Of Medicinal Chemistry, American Chemical Society, and Lexicon Pharmaceuticals.
How can I contact Nicole Goodwin?
You can use AeroLeads to view verified contact signals for Nicole Goodwin at Merck, including work email, phone, and LinkedIn data when available.
What schools did Nicole Goodwin attend?
Nicole Goodwin holds Ph.D., Organic Chemistry from Caltech.
What skills is Nicole Goodwin known for?
Nicole Goodwin is listed with skills including Medicinal Chemistry, Organic Chemistry, Organic Synthesis, Drug Discovery, Drug Design, Synthetic Organic Chemistry, and Project Management.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial